Antithrombotic Therapy After Acute Ischemic Stroke in Patients With Atrial Fibrillation [Clinical Sciences]

Share this content:
Antithrombotic Therapy After Acute Ischemic Stroke in Patients With Atrial Fibrillation [Clinical Sc
Antithrombotic Therapy After Acute Ischemic Stroke in Patients With Atrial Fibrillation [Clinical Sc
Background and Purpose- For patients with atrial fibrillation and ischemic stroke (IS), current guidelines recommend oral anticoagulation (OAC) alone for secondary prevention of IS. At discharge, 8.0% were prescribed no antithrombotic therapy, 21.6% antiplatelet therapy alone, 39.3% OAC (warfarin) alone, and 31.1% combination OAC and antiplatelet therapy.
READ FULL ARTICLE From Ahajournals
Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

is free, fast, and customized just for you!




Already a member?

Sign In Now »